Treatment of INR 2.3
An INR of 2.3 is within the therapeutic range for most indications and requires no reversal or intervention—continue warfarin at the current dose and monitor per standard protocol 1.
Clinical Context and Management
An INR of 2.3 falls squarely within the standard therapeutic range of 2.0-3.0 recommended for most anticoagulation indications 2, 3. This level provides effective thromboprophylaxis while minimizing bleeding risk.
No Intervention Required
For asymptomatic patients with INR 2.3:
- Continue current warfarin dose without adjustment 4
- No vitamin K administration needed 4
- No prothrombin complex concentrate (PCC) indicated 4
- Routine monitoring schedule maintained 5
The 2024 French guidelines explicitly state that asymptomatic INR values within or slightly outside the therapeutic range should be managed by maintaining the current dose and monitoring, not by reversal agents 4.
Monitoring Frequency
With a stable INR of 2.3:
- If recently initiated on warfarin: test 2-3 times weekly for 1-2 weeks, then weekly for 1 month 6
- If stable long-term: can extend to monthly testing 7
- Maximum interval between tests: 4-6 weeks for highly stable patients 8
Special Clinical Scenarios
If Bleeding Occurs at INR 2.3
Non-severe bleeding:
- Investigate and treat the bleeding source (not the INR itself) 4
- Consider symptomatic treatment
- Reassess anticoagulation indication and bleeding risk 4
- Generally continue warfarin if CHADS₂ score ≥2 9
Severe bleeding:
- Stop warfarin immediately
- Administer PCC 25-50 IU/kg plus vitamin K 10 mg IV 10, 4
- Check INR within 30 minutes, then at 6-8 hours and 24 hours 4
If Urgent Procedure Required
Low bleeding risk procedures:
High bleeding risk procedures:
- Stop warfarin 48-72 hours before procedure (allows INR to fall <1.5) 1
- For high thrombotic risk patients (mechanical mitral valve, recent VTE): bridge with therapeutic heparin when INR falls below 2.0 1
- For low thrombotic risk (bileaflet aortic valve, no risk factors): bridging usually unnecessary 1
Specific Indications
Atrial fibrillation: INR 2.3 is optimal—target range 2.0-3.0 7, 3
Mechanical heart valves:
- Aortic position: INR 2.3 is adequate (target 2.0-3.0) 1
- Mitral position: INR 2.3 is appropriate (target ≥2.5) 1
VTE treatment: INR 2.3 is therapeutic—target range 2.0-3.0 2
Common Pitfalls to Avoid
Do not adjust dose for single INR of 2.3 unless there's a clear trend or clinical indication 11. Recent evidence shows watchful waiting is as effective as dose changes for slightly out-of-range values, and 2.3 isn't even out of range 11.
Do not give vitamin K for INR 2.3 unless there is active bleeding requiring reversal 4. Unnecessary vitamin K creates difficulty with re-anticoagulation 1.
Do not routinely add heparin to therapeutic warfarin at INR 2.3 unless specifically indicated (e.g., acute coronary syndrome) 12, 13.
Avoid high-dose vitamin K (>10 mg) even if reversal is needed, as this creates a prothrombotic state and prevents re-warfarinization for days 10.